Quantcast

Latest Organofluorides Stories

2014-05-14 16:28:57

-- Difficult-to-treat squamous NSCLC patients saw clinical benefit with necitumumab plus chemotherapy regimen -- INDIANAPOLIS, May 14, 2014 /PRNewswire/ -- Lung cancer patients with metastatic squamous cell carcinoma have seen few treatment advancements over the last two decades, leaving these patients with a poor prognosis. This is in contrast to the progress seen in nonsquamous non-small cell lung cancer (NSCLC).[1] Results from the largest ever Phase III trial in first-line...

2014-05-14 16:23:27

DUBLIN, May 14, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/bztx8n/polyvinylidene) has announced the addition of the "Polyvinylidene Fluoride (PVDF) Market by End User Industry & by Application - Trends Forecasts to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The global polyvinylidene fluoride market, along with its applications, showed a significant growth in the past few years and is estimated to continue...

2014-05-14 08:31:42

SAN DIEGO, May 14, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. http://photos.prnewswire.com/prnvar/20090325/LA88762LOGO-b The discovery that our Hemopurifer® captures tumor-secreted exosomes provides hope for a new therapeutic paradigm to augment cancer care. Yes, the same Hemopurifier® we are preparing to advance in a forthcoming FDA approved infectious disease study. In my last CEO note, I...

2014-05-14 08:29:43

NORTHBROOK, Ill., May 14, 2014 /PRNewswire/ -- Astellas reported today that the efficacy and safety data of the isavuconazole invasive aspergillosis study (SECURE) were presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Barcelona, Spain. http://photos.prnewswire.com/prnvar/20140416/84970 Previously announced topline data showed that the randomized, double-blind SECURE study met the primary objective of demonstrating non-inferiority of...

2014-05-13 23:02:34

The Firm is representing Risperdal lawsuit clients who allegedly developed gynecomastia (male breast growth) due to their use of the antipsychotic drug. New York, New York (PRWEB) May 13, 2014 The Pennsylvania judge overseeing hundreds of Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) in the Philadelphia Court of Common Pleas has granted a defense motion to bar plaintiffs from seeking punitive damages. In an Order issued on May 2, 2014 Judge Arnold New ruled that the New...

2014-05-13 08:33:18

New submission based on positive data from a 15-month schizoaffective relapse prevention study TITUSVILLE, N.J., May 13, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc., today announced the submission of supplemental New Drug Applications (sNDAs) for once-monthly atypical long-acting antipsychotic INVEGA(®) SUSTENNA(®) (paliperidone palmitate) to the U.S. Food and Drug Administration (FDA) for approval to treat schizoaffective disorder as either monotherapy or adjunctive...

2014-05-12 23:09:29

Wright & Schulte LLC Files Effexor Lawsuit on Behalf of an Ohio Woman Who’s Child Was Born with Birth Defects Allegedly Due to the Antidepressant Drug Effexor Columbus, OH (PRWEB) May 12, 2014 An Effexor lawsuit was filed by Wright & Schulte LLC on behalf of an Ohio woman whose child was born with birth defects allegedly because she took the SSRI antidepressant drug Effexor while she was pregnan t. This Effexor lawsuit was filed in the U.S. District Court, Northern District of...

2014-05-08 23:07:06

GIA announces the release of a comprehensive global report on Polytetrafluoroethylene (PTFE) markets. Global market for Polytetrafluoroethylene (PTFE) is projected to reach 251.4 thousand tons by 2020, driven by recovery in global economic growth and expanding applications in automobile, construction and renewable energy sectors. San Jose, California (PRWEB) May 08, 2014 Follow us on LinkedIn – Polytetrafluoroethylene (PTFE) is a synthetic high molecular weight solid state fluorocarbon...

2014-05-07 23:14:54

Flood Law Group announced today that it is now available to investigate claims related to complications from taking prescription Invega extended release tablets. Invega, also known by its generic name paliperidone, may contribute to an increased risk of leukopenia and neutropenia and gynecomastica according to the FDA. Washington, D.C. (PRWEB) May 07, 2014 Flood Law Group released a statement today announcing that it is now available to investigate potential claims on behalf of people who...

2014-05-07 23:03:04

The Firm is representing Risperdal lawsuit clients who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic medication. New York, NY (PRWEB) May 07, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that a group of medical researchers is seeking physician participation in a national registry that tracks the use of atypical antipsychotic medications in pregnant...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related